RxDoctor Payments Data

Amy Carroll, MD

Gynecologic Oncology · Marietta, GANPI 1659575256

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.7% of the total across 217 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations.

$4,594in general payments, 2019–2025

Across 217 payments — averaging $21.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$742
  • AstraZeneca$664
  • Merck$596
  • Seagen Inc.$398
  • Tesaro, Inc.$281
  • Pfizer$249
  • plus $2K from 34 others

What the payments were for

  • Food & beverage$4,579100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,594 in reported general payments places this provider in the 60th percentile of 49 gynecologic oncology providers in Georgia.

See all gynecologic oncology providers in Georgia

Medicare billing

Part B allowed, 2024
$70,548
Medicare patients
132
Services billed
302

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol68$2,633
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen90$1,775
Gabapentin32$769
Clobetasol Propionate15$489
Nystatin27$418
Ondansetron Hcl35$380
Lidocaine-PrilocaineLidocaine/Prilocaine30$368
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen44$328
Ondansetron OdtOndansetron15$315
Prochlorperazine Maleate26$296
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst22$189
Oxycodone Hcl18$114

Paid to pharmacies, not to this prescriber.

Other gynecologic oncology in Marietta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →